Futuras estrategias terapéuticas en el tratamiento del cáncer de mama metastásico RE+/HER2-negativo: inhibidores CDK4/6 - page 8

CDKs
Evading growth
suppressors
CDK, cyclin-dependent kinase.
Mechanism of Acquired &
de novo
Resistance…
1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...40
Powered by FlippingBook